blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3830182

EP3830182 - HIGH-MOLECULAR-WEIGHT FUCANS FOR TREATING FIBROUS ADHESIONS AND OTHER DISEASES AND CONDITIONS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.05.2021
Database last updated on 05.10.2024
FormerThe international publication has been made
Status updated on  01.02.2020
Most recent event   Tooltip29.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Arc Medical Devices, Inc.
Unit 8, 3071 No. 5 Road
Richmond, British Columbia V6X 2T4 / CA
[2021/23]
Inventor(s)01 / SPRINGATE, Christopher Michael Kevin
Unit 8, 3071 No. 5 Road
Richmond, British Columbia V6X 2T4 / CA
02 / MILLET, Ian
Unit 8, 3071 No. 5 Road
Richmond, British Columbia V6X 2T4 / CA
03 / DASWANI, Sailesh Haresh
Unit 8, 3071 No. 5 Road
Richmond, British Columbia V6X 2T4 / CA
04 / SUN, Hesong
Unit 8, 3071 No. 5 Road
Richmond, British Columbia V6X 2T4 / CA
 [2021/23]
Representative(s)Stolmár & Partner Patentanwälte PartG mbB
Blumenstraße 17
80331 München / DE
[2021/23]
Application number, filing date19839914.924.07.2019
[2021/23]
WO2019CA51027
Priority number, dateUS201862711335P27.07.2018         Original published format: US 201862711335 P
US201862711364P27.07.2018         Original published format: US 201862711364 P
US201862711372P27.07.2018         Original published format: US 201862711372 P
US201862713392P01.08.2018         Original published format: US 201862713392 P
US201862713399P01.08.2018         Original published format: US 201862713399 P
US201862713413P01.08.2018         Original published format: US 201862713413 P
US201862722135P23.08.2018         Original published format: US 201862722135 P
US201862722137P23.08.2018         Original published format: US 201862722137 P
US201862755311P02.11.2018         Original published format: US 201862755311 P
US201862755318P02.11.2018         Original published format: US 201862755318 P
US201862755328P02.11.2018         Original published format: US 201862755328 P
US201962793514P17.01.2019         Original published format: US 201962793514 P
US201962793654P17.01.2019         Original published format: US 201962793654 P
US201962861223P13.06.2019         Original published format: US 201962861223 P
US201962861228P13.06.2019         Original published format: US 201962861228 P
US201962861235P13.06.2019         Original published format: US 201962861235 P
[2021/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020019078
Date:30.01.2020
Language:EN
[2020/05]
Type: A1 Application with search report 
No.:EP3830182
Date:09.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 30.01.2020 takes the place of the publication of the European patent application.
[2021/23]
Search report(s)International search report - published on:CA30.01.2020
(Supplementary) European search report - dispatched on:EP27.05.2022
ClassificationIPC:C08B37/00, A61K31/737, A61P41/00, C08L5/00
[2022/26]
CPC:
A61P41/00 (EP,IL,US); C08B37/0003 (EP,IL,KR,US); A61K31/737 (EP,IL,KR,US);
A61K41/00 (KR); A61K47/02 (US); A61K9/0034 (EP);
C08B37/0063 (EP,IL,KR,US); C08L5/00 (EP,IL,KR) (-)
Former IPC [2021/23]C08L5/00, A61K31/737, A61P41/00, C08B37/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/23]
TitleGerman:HOCHMOLEKULARE FUCANE ZUR BEHANDLUNG VON FASERIGEN ADHÄSIONEN UND ANDEREN KRANKHEITEN UND ZUSTÄNDEN[2021/23]
English:HIGH-MOLECULAR-WEIGHT FUCANS FOR TREATING FIBROUS ADHESIONS AND OTHER DISEASES AND CONDITIONS[2021/23]
French:FUCANES DE POIDS MOLÉCULAIRE ÉLEVÉ POUR LE TRAITEMENT D'ADHÉSIONS FIBREUSES ET D'AUTRES MALADIES ET AFFECTIONS[2021/23]
Entry into regional phase14.01.2021National basic fee paid 
14.01.2021Search fee paid 
14.01.2021Designation fee(s) paid 
14.01.2021Examination fee paid 
Examination procedure21.04.2020Request for preliminary examination filed
International Preliminary Examining Authority: CA
14.01.2021Examination requested  [2021/23]
24.01.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
03.04.2023Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
31.03.2023Request for further processing filed
31.03.2023Full payment received (date of receipt of payment)
Request granted
11.04.2023Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
31.03.2023Request for further processing filed
31.03.2023Full payment received (date of receipt of payment)
Request granted
11.04.2023Decision despatched
Fees paidRenewal fee
31.07.2021Renewal fee patent year 03
31.07.2022Renewal fee patent year 04
31.07.2023Renewal fee patent year 05
29.07.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]US2009170801  (HAO SHOUZHU [CN]) [X] 1-7,9-16,19,20 * paragraphs [0003] , [0 21] , [0 22] , [0 23] * * Table;; examples 1-2 * * paragraph [0051] * [I] 21;
 [A]US2011021457  (SPRINGATE CHRISTOPHER MICHAEL KEVIN [CA]) [A] 1-21 * paragraphs [0032] - [0035] ** examples 1-6 *;
 [XI]  - FITTON JANET ET AL, "Therapies from Fucoidan: An Update", MARINE DRUGS, Basel, CH, (20160906), vol. 13, no. 9, doi:10.3390/md13095920, ISSN 1660-3397, pages 5920 - 5946, XP055848218 [X] 1-19 * abstract * * page 5924; table 1 * [I] 20,21

DOI:   http://dx.doi.org/10.3390/md13095920
International search[X]US8426381  (THIBODEAU ALAIN [CA], et al) [X] 104-111, 115-120;
 [X]CN105399848  (SHANGHAI INST MATERIA MEDICA CAS) [X] 1-84, 121-138 * google translation. *;
 [X]CN106832022  (WEIHAI YUWANG GROUP CO LTD) [X] 85-94, 111-114 * abstract google patents *;
 [X]US2018051097  (SPRINGATE CHRISTOPHER MICHAEL KEVIN [CA]) [X] 1-84;
 [X]  - Chizhov A O; Dell A; Morris H R; Haslam S M; McDowell R A; Shashkov A S; Nifant'ev N E; Khatuntseva E A; Usov A I, "A study of fucoidan from the brown seaweed Chorda filum", Carbohydrate Research, (19990720), vol. 320, no. 1-2, doi:10.1016/S0008-6215(99)00148-2, ISSN 0008-6215, pages 108 - 119, XP004184168 [X] 1-84, 121-138 * . (whole document) *

DOI:   http://dx.doi.org/10.1016/S0008-6215(99)00148-2
 [X]  - Mingyi Wu; Li Xu; Longyan Zhao; Chuang Xiao; Na Gao; Lan Luo; Lian Yang; Zi Li; Lingyun Chen; Jinhua Zhao, "Structural Analysis and Anticoagulant Activities of the Novel Sulfated Fucan Possessing a Regular Well-Defined Repeating Unit from Sea Cucumber", Marine Drugs, (20150413), vol. 13, no. 4, doi:10.3390/md13042063, ISSN 1660-3397, pages 2063 - 2084, XP055681847 [X] 139-146 * . *

DOI:   http://dx.doi.org/10.3390/md13042063
 [X]  - Pereira M S; Melo F R; Mourao P A S, "Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans", Glycobiology, (20021001), vol. 12, no. 10, doi:10.1093/glycob/cwf077, ISSN 0959-6658, pages 573 - 580, XP055244172 [X] 139-146

DOI:   http://dx.doi.org/10.1093/glycob/cwf077
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.